![Lisa Caperelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lisa Caperelli
Investor Relations Contact bij
ARDELYX, INC.
Profiel
Lisa M.
Caperelli is currently Director at National Investor Relations Institute and Head-Investor & Media Relations at Ardelyx, Inc. Former roles include Director-Investor Relations & Communications at PolyMedix, Inc. from 2009 to 2013, Executive Director-Investor & Strategic Relations at Immedica Pharma US, Inc. from 2014 to 2020, President & Director at NIRI Philadelphia Chapter from 2020 to 2022, Senior Director-Investor Relations at Advaxis, Inc. in 2014, Head-Investor Relations at Windtree Therapeutics, Inc. from 2001 to 2009, Head-Investor Relations at Harmony Biosciences Holdings, Inc. from 2020 to 2021, and Vice President-Investor Relations at Arbutus Biopharma Corp.
Education includes undergraduate studies at Delaware Valley University.
Actieve functies van Lisa Caperelli
| Bedrijven | Functie | Begin |
|---|---|---|
| ARDELYX, INC. | Investor Relations Contact | 01-03-2026 |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Directeur/Bestuurslid | - |
Eerdere bekende functies van Lisa Caperelli
| Bedrijven | Functie | Einde |
|---|---|---|
| HARMONY BIOSCIENCES HOLDINGS, INC. | Investor Relations Contact | 01-01-2021 |
| MARINUS PHARMACEUTICALS, INC. | Investor Relations Contact | 01-03-2020 |
| AYALA PHARMACEUTICALS, INC. | Investor Relations Contact | 01-10-2014 |
| POLYMEDIX, INC. | Investor Relations Contact | 01-01-2013 |
| WINDTREE THERAPEUTICS, INC. | Public Communications Contact | 01-12-2009 |
Opleiding van Lisa Caperelli
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
63
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Windtree Therapeutics, Inc.
 Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets | Health Technology |
PolyMedix, Inc.
 PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic small molecule compound drugs | Health Technology |
Marinus Pharmaceuticals, Inc.
 Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Delaware Valley University
 Delaware Valley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Commercial Services |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
NIRI Philadelphia Chapter
 NIRI Philadelphia Chapter Miscellaneous Commercial ServicesCommercial Services Provides timely information, cutting-edge programs and exciting networking opportunities to NIRI members | Commercial Services |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
